Document Detail

Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin.
MedLine Citation:
PMID:  2123159     Owner:  NLM     Status:  MEDLINE    
The incidence of abnormal endometrial histology in patients undergoing human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) treatment during cycles of in vitro fertilization (IVF) or gamete intrafallopian transfer has been reported to be 52% to 91%. The incidence of endometrial inadequacy, as judged by a single late luteal endometrial biopsy, has not been studied in hMG/hCG non-IVF cycles. In the current study, 30 patients (30 cycles) undergoing hMG/hCG treatment were evaluated by an endometrial biopsy. The incidence of endometrial inadequacy was found to be 27%. No preovulatory predictors for endometrial inadequacy could be identified. Therefore, luteal support for patients undergoing non-IVF hMG/hCG cycles should be considered.
E Reshef; J H Segars; G A Hill; D D Pridham; M A Yussman; A C Wentz
Related Documents :
16764619 - Effects of metformin on insulin resistance, androgen concentration, ovulation and pregn...
16954409 - Comparison of different gonadotrophin preparations in intrauterine insemination cycles ...
3966169 - Reproductive performance of patients treated with clomiphene citrate.
2707459 - Ovarian superstimulation in the treatment of infertility due to peritubal and periovari...
2123759 - Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimula...
18567899 - What is the most accurate estimate of pregnancy rates in ivf dropouts?
17572919 - Myelomeningocele: a review of the epidemiology, genetics, risk factors for conception, ...
8029669 - When pregnant--why induced abortion?
2872469 - Radioimmunoassay of relaxin in pregnancy with an analogue of human relaxin.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Fertility and sterility     Volume:  54     ISSN:  0015-0282     ISO Abbreviation:  Fertil. Steril.     Publication Date:  1990 Dec 
Date Detail:
Created Date:  1991-01-09     Completed Date:  1991-01-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1012-6     Citation Subset:  IM    
Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Kentucky.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chorionic Gonadotropin / adverse effects*,  therapeutic use
Endometrium / drug effects,  pathology*
Estradiol / metabolism
Luteal Phase
Menotropins / adverse effects*,  therapeutic use
Menstrual Cycle / drug effects
Ovarian Follicle / metabolism
Reference Values
Reg. No./Substance:
0/Chorionic Gonadotropin; 50-28-2/Estradiol; 61489-71-2/Menotropins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early follicular phase follicle-stimulating hormone treatment of endometrial luteal phase deficiency...
Next Document:  Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 w...